School of Medicine
Showing 101-150 of 343 Results
-
Jen Haensel
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.
I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots. -
Md Enamul Haque
Biostatistician 3, Ophthalmology Research/Clinical Trials
Current Role at StanfordSr. Research Scientist
-
Mary Elizabeth Hartnett, MD
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology. In recognition of her lifetime contributions, she was inducted into the Retina Hall of Fame and was elected to the Association of American Physicians in 2025.
Dr. Hartnett's prolific publication record includes 295 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as the Treasurer for The Macula Society and the Chair of the Jack McGovern Coats Disease Foundation as well as the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Quan (Donny) V. Hoang, MD, PhD
Clinical Associate Professor, Ophthalmology
Current Research and Scholarly InterestsDr. Hoang's research focuses on extreme near-sightedness, a significant cause of blindness, especially in Southeast Asia. While mild myopia is merely inconvenient, pathologic myopia involves extreme levels of lifelong, progressive eye elongation and eyewall thinning that can lead to blindness. He employs cutting-edge non-invasive imaging to identify patients at greatest risk of vision loss, and leads lab-based studies to discover novel treatments to stunt near-sightedness.and prevent blindness.
-
Wen Hong
Postdoctoral Scholar, Ophthalmology
BioDr. Wen Hong was a postdoctoral researcher at UCLA, specializing in 3D printing of metals, hydrogels, and liquid metal. She earned her Ph.D. in Electrical Engineering from Shanghai Jiao Tong University, where she focused on flexible and implantable MEMS devices. Her research integrates materials science, bioelectronics, and soft robotics to develop innovative biomedical devices.
Her work covers high-resolution light-based 3D printing, self-adaptive cardiac optogenetics, and multifunctional flexible sensors. With expertise in cleanroom fabrication, semiconductor failure analysis, and finite element modeling, she has contributed to advancing bio-integrated technologies. Her research has been published in journals such as Science Advances and Sensors and Actuators A. Her long-term research goal is to push the boundaries of bioelectronics and soft robotic systems for healthcare applications. -
Yang Hu, MD, PhD
Professor of Ophthalmology
On Partial Leave from 01/05/2026 To 07/31/2026Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Jia-Horung Hung, MD, PhD
Clinical Instructor, Ophthalmology
BioDr. Hung is a fellowship-trained ophthalmologist, practicing at the Byers Eye Institute, and also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Hung specializes in diagnosing and treating ocular inflammatory diseases, such as uveitis, iridocyclitis, and scleritis, as well as retinal vascular diseases, including age-related macular degeneration and diabetic retinopathy.
Dr. Hung’s research interests include ocular inflammation, infections, hereditary ocular inflammatory diseases, and novel approaches in managing ocular inflammatory diseases. His research has advanced screening, diagnostics, and treatment for patients with uveitis, lens disorders, retinal diseases, glaucoma, and rare ocular conditions. Dr. Hung’s most recent research explores the use of artificial intelligence (AI) to improve the identification of ocular inflammatory diseases.
Dr. Hung has published his work in major national and international peer-reviewed journals, including American Journal of Ophthalmology, British Journal of Ophthalmology, RETINA, Clinical & Experimental Ophthalmology, and Survey of Ophthalmology. He has presented at national and international conferences on the use of technology in uveitis management.
Dr. Hung is a member of many professional organizations, including the American Society of Retina Specialists, the International Ocular Inflammation Society, the Foster Ocular Immunology Society, and the European Society of Retina Specialists. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
James Regun Karmoker
Postdoctoral Scholar, Ophthalmology
BioDr. James Regun Karmoker started his career as a Lecturer at the University of Asia Pacific, Bangladesh, after completing his B. Pharm and MS Pharm Tech from the same university. He obtained a doctorate degree in Vision Science from the University of Oklahoma, USA, where he studied immune cell activation in the context of retinal pigment epithelium injury. Currently, he is a postdoctoral scholar in Prof. Mary Elizabeth Hartnett’s lab studying age-related macular degeneration.
-
Ryan Keenan, OD
Clinical Assistant Professor, Ophthalmology
BioDr. Keenan is a board-certified optometrist with the Stanford Health Care Byers Eye Institute and a clinical assistant professor in the Department of Ophthalmology.
Dr. Keenan diagnoses and treats a wide range of ocular and visual issues, such as vision problems related to stroke, intracranial lesions and tumors, and other neurological conditions. His clinical experience involves recognizing and caring for complex neuro-ophthalmic diseases. These include complications from diseases of the nervous system that adversely affect vision.
Dr. Keenan’s research interests include understanding genetic variations related to progressive weakness of the eye muscles. These conditions range from drooping eyelids to increasing limitations in eye movement.
Dr. Keenan has presented research and clinical findings to his peers at national and regional meetings, including the annual meetings of the American Academy of Optometry and the North American Neuro-Ophthalmology Society. -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science. Khaderi developed the discipline of Symbiotics following initial interest from CS students interested in his research at the Stanford Human Perception Lab. Symbiotics involves a deep understanding in the principles of human systems and applying these principles computationally, to design and develop the next generation of human-centric technologies, where machines perceive, understand and respond to optimize the human experience. Dr. Khaderi envisions the application of Symbiotic principles as the key to unlocking ambient intelligence.
Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including Apple, Google, Meta, Microsoft, Riot Games, Intel, Activision, Unity, Epic Games, NBA, Glaukos, the Global Esports Federation, the World Health Organization, the International Olympic Committee, the International Telecommunication Union, and the World Bank. -
Hyeonji Kim
Visiting Instructor/Lecturer, Ophthalmology
BioDr. Kim is a translational bioprinting researcher specializing in tissue engineering and ocular regenerative medicine. She holds a Ph.D. in Mechanical Engineering. Her research focuses on developing innovative therapeutic platforms for ocular diseases using 3D bioprinting, biomanufacturing, and regenerative medicine.
She has developed 3D-bioprinted corneal stromal constructs that replicate native collagen alignment and achieve transparency, successfully restoring visual function in preclinical beagle models and subsequent veterinary clinical applications. She also advanced a simplified in situ corneal therapy that has completed veterinary clinical trials and is now licensed for anticipated human trials. Currently, she is developing ocular therapeutic implants using advanced 3D printing approaches.
Dr. Kim has collaborated with regulatory authorities and preclinical evaluation agencies to define guidelines for 3D-printed combination medical devices and to conduct safety testing of bioprinted corneas. Her work has been internationally recognized, contributing to her university's ranking as 12th in Reuters’ 2019 “Top 100 Most Innovative Universities,” and spans drug delivery, diagnostic and therapeutic devices, personalized medicine, and translational ophthalmology. Her long-term vision is to engineer personalized therapeutic implants and biofabrication technologies that bridge fundamental science and clinical translation, initially focusing on restoring vision and ultimately expanding to regenerative therapies for multiple organ systems. -
Benyam Z. Kinde, MD, PhD
Assistant Professor of Ophthalmology
BioDr. Kinde is a board-certified, fellowship-trained ophthalmologist and ophthalmic plastic and reconstructive surgeon at Stanford Health Care Byers Eye Institute. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine. Dr. Kinde completed the American Society of Ophthalmic and Plastic Reconstructive Surgery (ASOPRS) fellowship in ophthalmic plastic surgery through the Bascom Palmer Eye Institute at the University of Miami.
Dr. Kinde diagnoses and treats a wide range of conditions related to the eyelid and other eye structures, including facial nerve palsy, skin cancer, and thyroid eye disease. He also provides care for patients who wish to enhance their appearance through surgical and nonsurgical interventions. Dr. Kinde offers many types of treatments, including cosmetic surgery, eyelid surgery (including upper and lower eyelid blepharoplasty and ptosis surgery), reconstructive surgery, tear duct (lacrimal) surgery, and orbital surgery.
Dr. Kinde is a physician-scientist whose research interests focus on developing new tools to promote survival of retinal ganglion cells after optic nerve injury. He has investigated how modulating the DNA damage response in mouse models of traumatic optic neuropathy (symptoms of nerve damage) may promote and improve optic nerve function after injury. His previous work focused on increasing the resilience of neurons (messaging nerve cells) in mouse models of glaucoma and in humans with glaucoma. He completed his MD and PhD in neuroscience at Harvard Medical School, where his thesis work revealed a new understanding of Rett syndrome, a rare genetic disorder that affects body movement.
Dr. Kinde has published in many peer-reviewed journals, including Nature, Science, Cell, Ophthalmology, and Facial Plastic Surgery & Aesthetic Medicine. He has presented to his peers at international and national meetings, including the Association for Research in Vision and Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, and Inter-American Course in Clinical Ophthalmology. -
Eubee Baughn Koo
Clinical Assistant Professor, Ophthalmology
BioDr. Koo is a board-certified ophthalmologist with the Byers Eye Institute at Stanford Health Care and a clinical assistant professor in the Department of Ophthalmology.
Dr. Koo diagnoses and treats a wide range of eye conditions, such as blepharitis, macular degeneration, diabetic retinopathy, farsightedness, cataracts, and glaucoma. She performs a range of surgical procedures, including cataract surgery, chalazia excisions, and laser glaucoma surgery. Dr. Koo creates a comprehensive, personalized treatment plan for each of her patients.
In addition to her clinical responsibilities, Dr. Koo is involved in the education and oversight of medical students, interns, and Ophthalmology residents spanning all settings from the classroom to the clinic, operating room, and the hospital.
Dr. Koo researches best practices in ophthalmologic care. Her research has included case studies to evaluate treatments in adults and children.
Dr. Koo’s work has been published in peer-reviewed journals, including Retina and the Journal of Pediatric Ophthalmology and Strabismus. She has been invited to moderate and present at regional, national, and international meetings, including the World Ophthalmology Congress. -
Euna Koo, MD
Clinical Associate Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Koo is an ophthalmologist specializing in pediatric ophthalmology and adult strabismus. She received her ophthalmology training at UC San Francisco and then her fellowship training in pediatric ophthalmology and adult strabismus at Boston Children's Hospital affiliated with Harvard Medical School. She has been board certified by the American Board of Ophthalmology since 2016. Her practice reflects her clinical interests in pediatric ophthalmology and in adult strabismus.
She utilizes Botox in management of adult and pediatric strabismus. She also uses hidden adjustable sutures in children and adults to optimize alignment of eyes with surgery. Muscles can be adjusted up to 7-10 days after surgery.
She is active in training both residents and fellows in ophthalmology. -
Edward Korot
Adjunct Clinical Instructor, Ophthalmology
BioI’m a vitreoretinal surgeon guided by the goal of maximally scaling improvements in patients’ lives through technology.
My work involves medical AI validation, guideline development, safety, quantifying model uncertainty, AI-driven pharmaceutical trial recruitment, partner management, and UX research.
Currently, I’m an adjunct faculty at Stanford, and practicing in Michigan. When not working, you can find me doing yoga, practicing drone photography and playing tennis. -
Andrea Lora Kossler, MD, FACS
Associate Professor of Ophthalmology and, by courtesy, of Otolaryngology - Head & Neck Surgery
Current Research and Scholarly InterestsThyroid Eye Disease
Adenoid Cystic Carcinoma of the Lacrimal Gland
Lacrimal Gland Stimulation for the Treatment of Dry Eyes
Neurostimulation
Orbital Tumors
Floppy Eyelid Syndrome and Obstructive Sleep Apnea -
Karteek Kunala
Research Engineer, Ophthalmology Research/Clinical Trials
BioMy current interests are in development of design and instrumentation of pre-clinical vision devices, to conduct non-invasive in vivo retinal imaging. I studied Physics with a concentration in optics during my time at University of Hyderabad, India and received a bachelors and masters degree in 2014. I then moved to USA to continue working in the field of optics at University of North Carolina at Charlotte to pursue my PhD, working on nanofabrication of broadband anti-reflective structures. My interest in vision science started with my job at University of Rochester as a research scientist, where I was involved in developing optical imaging tools using adaptive optics to study retinal diseases. My work was focused on development of fluorescence lifetime imaging techniques in humans and two photon fluorescence microscopy in mouse.
-
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
